Our team consists of experienced investment professionals with extensive expertise in investing and building healthcare companies, with complementary backgrounds in drug development, finance, science and technology. In addition, our team is supported by a dedicated team of seasoned senior scientific and business advisors and has access to a broad network within academia, finance and industry. We take an active role in the development of our portfolio companies as a lead investor or as an active syndicate partner.
